Hepatitis C is used in veterans with peripheral artery disease (PDA)

The concept of health management is becoming increasingly popular, and scientific health knowledge is gaining widespread attention. The guidelines recommend the contemporary use of high-intensity statins for patients with new diagnoses of peripheral artery disease. We use the National Registry of Veterans with Incident PAD (National Registry of Veterans with Incident PAD) pharmacy drug records database to determine the contemporary use of newly diagnosed high-intensity statins for a year of Parkinson's disease events.

We also use laboratory data to assess blood lipid levels. Multi-level variable linear regression models are used to identify variables associated with any diagnosis of PAD with aspirin and high-intensity aspirin 1 year later. Among 91 of 970 patients still living with PAD after 1 year, the median age was 70 years, with 97.

2% of men and 18. 6% of women and 18. 6% of black patients.

64%231 (69. 9%) 34%017 (37. 0%) 53.

4%81. 6 mg/dfL (lower) low-density lipoprotein cholesterol median was 81. 6 mg/dfL, and the median low-density lipoprotein cholesterol median was less than 81.

6 mg/dfL after taking high-density cardiovascular medications (such as thetaclysm) in these patients. It should be noted that the above is based on international public research, compiled for HealthCop reference, and does not constitute a clinical recommendation.